Tissue reactions induced by different embolising agents in cerebral arteriovenous malformations: a histopathological follow-up

Pathology. 2006 Feb;38(1):28-32. doi: 10.1080/00313020500455795.

Abstract

Aims: Comparative histopathological analysis was performed in 47 incompletely embolised and resected cerebral arteriovenous malformations (AVMs).

Methods: Thirty-three AVMs were embolised with n-butyl-cyanoacrylate (NBCA), four with iso-butyl-cyanoacrylate (IBCA), seven with polyvinyl alcohol particles (PVA), one with a fibrin mixture, one with silicon pellets, and one with microcatheter balloons. Maximum exposure time (MET) of the embolising agent (interval between embolisation and surgery) ranged from <24 hours to 80 months. All AVMs were investigated regarding angionecrosis, angiofibrosis, acute inflammation, chronic inflammation, foreign-body reactions, vascular calcification, blood admixture to embolising cast, and capillary recanalisation within the AVMs. These parameters were correlated with MET, comparing different embolising agents, age, and sex.

Results: A typical sequence of events depending on MET is observed in all embolised AVMs: acute inflammation with mural angionecrosis is soon replaced by prominent chronic granulomatous vasculitis, which remains stable and is detectable for a very long time, even in AVMs with a MET of more than 6 years.

Conclusion: Capillary recanalisation is always present in incompletely embolised AVMs, detectable after 3 months of MET, irrespective of the embolising agent used. Age and sex does not influence pattern and time course of tissue lesions and recanalisation in incompletely embolised AVMs.

Publication types

  • Comparative Study

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Bucrylate / therapeutic use*
  • Capillaries / pathology
  • Catheterization
  • Child
  • Cyanoacrylates / therapeutic use*
  • Embolization, Therapeutic*
  • Enbucrilate
  • Female
  • Fibrin / therapeutic use
  • Follow-Up Studies
  • Humans
  • Intracranial Arteriovenous Malformations / pathology*
  • Intracranial Arteriovenous Malformations / therapy*
  • Male
  • Middle Aged
  • Polyvinyl Alcohol / therapeutic use*
  • Silicon / therapeutic use
  • Time Factors
  • Vasculitis / pathology

Substances

  • Cyanoacrylates
  • Bucrylate
  • Fibrin
  • Polyvinyl Alcohol
  • Enbucrilate
  • Silicon